Deutsche Bank has discontinued Kursziel for Novo Nordisk after a Kaufempfehlung after Investing.com’s Q3 Announcement Party

On Donnerstag, a Deutschen Bank analyst passed Kursziel for Novo Nordisk (NOVOB:DC) (NYSE: NYSE:), a wealthy company with health insurance of DKK 1,100.00 to DKK 1,000.00 per year. Trotz has added the analysis of the analyst’s analysis for the Action.

The analysis was carried out after analyzing the quarters of the new Nordisk and the market reaction to the financial forecast of the future. As the trading phases of the new Nordisk action begin a beach change, the analyst begins to explore a number of different aspects in his research as a “bigger” institution.

In the broadcast of a telephone conference, when the new Nordisk was an Ausblick at the Umsatzentwicklung for the Geschäftsjahr 2025, which gave the Euphoria on the market a verhaltene Stimmung. Our predictions for 2025 are one of the latest developments in the future. This forecast is based on Deutschen Bank models and market expectations with tomorrow’s estimated interest rates of 19% to 20%.

Dennoch interpreted the market that other predictions, was one of the most important choices made by the Kursgewin fuehrte. The Deutschen Bank analyst argued that the market reaction in the US market could potentially trigger a war in 2025. If you get an idea of ​​the prediction of the best results from the best mind, analyzing your Sorge will not help you.

This description can be performed by the intelligent intelligence. Weitere Informationen entnehmen Sie bitte unseren Nutzungsbedingungen.